Ensemble Therapeutics
About Us Our Science & Technology Our Pipeline News & Publications Careers Contact Us

Ensemble Therapeutics is focused on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. We are leveraging our proprietary drug discovery platform to develop novel small molecules to drug well-validated, but challenging disease targets that are not currently addressed by conventional small molecules or antibodies.

Ensemble is building a growing pipeline of synthetic macrocycles and other novel small molecule therapies that expand the boundaries of traditional therapeutics to work against important disease targets inside or outside cells.


4/1/2015 - Ensemble is pleased to announce the publication of a paper in the Journal of Medicinal Chemistry that describes the use of DPC macrocyclic libraries in the discovery of novel XIAP antagonists. These macrocycles are potent pro-apoptotic agents, and are effective in shrinking tumors in a mouse xenograft model



Sitemap | Legal | Contact Us © 2010 Ensemble Therapeutics
design by Digizyme